A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
Latest Information Update: 01 Aug 2024
At a glance
- Drugs Rimegepant (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 30 Jul 2024 Planned End Date changed from 15 Aug 2024 to 10 Dec 2024.
- 30 Jul 2024 Planned primary completion date changed from 1 Aug 2024 to 20 Aug 2024.
- 30 Jul 2024 Status changed from recruiting to active, no longer recruiting.